Miglustat-impurities | Pharmaffiliates


Miglustat is used to treat adults with mild-to-moderate type I Gaucher disease for whom enzyme replacement therapy is unsuitable. It is marketed under the trade name Zavesca. Reference standards of Miglustat API,and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below.

PA STI 016160

N-Butyldeoxynojirimycin Hydrochloride-d9

  • Catalogue No.:PA STI 016160

  • CAS :


  • Molecular Formula : C10H13D9ClNO4

  • Molecular Weight : 264.79